BIONOMICS LIMITED - AMERICAN DEPOSITORY SHARES
0.7103
08-July-24 12:53:14
15 minutes delayed
Stocks
+0.0285
+4.18%
Today's range
0.7100 - 0.7400
ISIN
N/A
Source
NASDAQ
-
Bionomics Reports Topline Results in PREVAIL Phase 2 Study of BNC210 in Social Anxiety Disorder
18 Dec 2022 19:34:26 By Nasdaq GlobeNewswire
-
Bionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive Officer
15 Dec 2022 18:35:25 By Nasdaq GlobeNewswire
-
02 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
21 Nov 2022 18:13:51 By Nasdaq GlobeNewswire
-
16 Nov 2022 18:36:15 By Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in Upcoming November Investor Conferences
02 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
Quarterly Activities Report for September 2022
25 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million
18 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference
04 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder
21 Sep 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics to Participate in Upcoming September Investor Conferences
31 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics reports Full Year Financial Results
25 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics Receives R&D Tax Incentive Refund for FY2021 of A$2.1M
08 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
Quarterly Activities Report for June 2022
29 Jul 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics to Participate in William Blair’s Biotech Focus Conference 2022
08 Jul 2022 06:00:00 By Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in the H.C. Wainwright Mental Health Conference
27 Jun 2022 06:00:00 By Nasdaq GlobeNewswire
-
13 Jun 2022 16:30:00 By Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in Upcoming Investor Conferences
16 May 2022 06:00:00 By Nasdaq GlobeNewswire
-
23 Feb 2022 21:00:22 By Nasdaq GlobeNewswire